IDT Australia Limited announced the cessation of 861,000 ordinary fully paid securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being ...

Gelteq Limited partners with IDT Australia to establish a manufacturing facility for gel-based pharmaceutical and nutraceutical products.

IDT is internationally recognized for its expertise in pharmaceutical projects and contract manufacturing services developed across more than 50 years of operation and over 60 market-based drugs.

IDT Australia, with over 50 years of pharmaceutical manufacturing experience, specializes in pharmaceutical product development and cGMP manufacturing, including high containment production of ...

Paul McDonald, CEO of IDT Australia, commented:“ We are excited to combine IDT's proven development and manufacturing capabilities with Gelteq's innovative delivery system for wellness and ...

Paul McDonald, CEO of IDT Australia, commented: “ We are excited to combine IDT’s proven development and manufacturing capabilities with Gelteq’s innovative delivery system for wellness and ...